ArticleBMC oral health2025
Periodontal health, xerostomia and oral health-related quality of life in controlled vs. uncontrolled type 2 diabetes mellitus patients.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reliable assessment of oral dryness in adults with type 2 diabetes mellitus using the Romanian version of the Summated Xerostomia Inventory.Frontiers in oral health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes mellitus is a complex endocrine condition affecting the periodontal status of an individual. The current study aimed to assess oral health related quality of life (OHRQL), xerostomia severity, and periodontal status in both controlled and uncontrolled Type 2 Diabetes mellitus. (T2DM)
methodsEighty patients with type 2 diabetes aged between 35 and 70 were divided equally in Group I: patients with controlled T2DM and Group II: patients with uncontrolled T2DM. Clinical attachment level (CAL), probing depth (PD), and bleeding on probing (BOP) parameters were assessed. Additionally, xerostomia severity was determined through questionnaire of 11-point xerostomia inventory and OHRQL through 14-point oral health impact profile. (OHIP-14)
resultsThe mean HbA1C values differed significantly in the two groups with Group I exhibiting values of 6.97 ± 0.45 gm% and Group II with 9.78 ± 2.31 gm%. The patients in Group II had significantly higher mean PD, CAL, and BOP values in comparisonto Group I. Similar corresponding values were obtained for xerostomia severity and OHIP-14 scores for OHRQL. On comparison between the groups the periodontal status manifested by clinical parameters exhibited more severity while xerostomia severity and OHRQL, was negatively impacted in Group II patients when compared with Group I.
conclusionPoor glycaemic control substantially influences periodontal health, xerostomia severity, and oral health-related quality of life. Early periodontal intervention and maintenance of optimal glycaemic control are crucial to improve overall oral and systemic health in diabetic patients. TRIAL REGISTRATION NUMBER: CTRI/2025/04/086064 Date: 30 April 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.